Key result
Genetic testing for short QT syndrome remains low yield despite known potassium channel mutations.
This review summarizes the cellular mechanisms, genetics, clinical presentation, and management of short QT syndrome.
Answers are grounded in this paper and cite their sources.
Genetic testing yield remains low in short QT syndrome; leaves open need for expanded registries and novel variant discovery.
Short QT syndrome is a rare inherited autosomal dominant cardiac channelopathy associated with malignant ventricular and atrial arrhythmias. A shortened corrected QT interval is a marker for risk of malignant arrhythmias, which are secondary to increased transmural dispersion of repolarization. The underlying gain of function mutations in the potassium channels are most common but genetic testing remains low yield. This review discusses the cellular mechanisms, genetic involvement, clinical presentation, and current recommended management of patients with short QT syndrome relevant to current clinical practice.
No takes yet. Share an insight, caveat, or question.
Khera et al. (2015) conducted a review in Short QT syndrome. Short QT syndrome is a rare inherited channelopathy associated with malignant arrhythmias, for which genetic testing remains low yield despite known potassium channel mutations.
Synapse has enriched 10 related papers. Consider them for comparative context: